title: Hypogammaglobulinemia in pediatric liver transplant recipients.
abstract: Hypogammaglobulinemia has been reported after solid organ transplantation in adults, however immunoglobulin replacement [intravenous immunoglobulins (IVIG)] is only necessary in a minority of affected patients. We here present three pediatric patients with severe post-transplant hypogammaglobulinemia following liver transplantation (LTx) receiving a cyclosporine-based standard immunosuppression. Patient 1 was transplanted at the age of 10 months for biliary atresia. Eight weeks post-Ltx the serum IgG was 1.7 g/L. Patient 2 was transplanted at the age of 12 yr for acute liver failure. Four weeks post-Ltx the IgG dropped to 2.6 g/L. Patient 3 was transplanted at the age of 4 months for biliary atresia. Ten weeks post-Ltx severe hypogammaglobulinemia (IgG < 1.48 g/L) was diagnosed during a severe infectious complication. Patients 1 and 3 received a steroid bolus therapy for acute graft rejection. All patients had normal IgG concentrations prior to Ltx and lymphocyte subsets were post-operatively in the normal range. There was no extensive loss of protein by ascites. IGIV were replaced in the three patients monthly without further complications. In two of the patients (1 and 3) IVIG therapy was discontinued 8 and 10 months after Ltx when the immunosuppression has been reduced and serum IgG concentrations were found in the normal range without further immunoglobulin replacement. Severe hypogammaglobulinemia is a rare phenomenon following pediatric LTx and seems to be mainly caused by immunosuppressive drugs, however, the exact underlying mechanisms are unclear. A screening for hypogammaglobulinemia is useful after pediatric LTx, especially in patients with an intensified immunosuppression. Moreover, further immunologic research in affected patients is necessary.
authors.affiliation: Department of Pediatrics, University of Hamburg, Germany. ganschow@uke.uni-hamburg.de
authors.forename: R
authors.initials: R
authors.lastname: Ganschow
authors.forename: C
authors.initials: C
authors.lastname: Englert
authors.forename: E
authors.initials: E
authors.lastname: Grabhorn
authors.forename: A
authors.initials: A
authors.lastname: Richter
authors.forename: B
authors.initials: B
authors.lastname: Hinrichs
authors.forename: D C
authors.initials: DC
authors.lastname: Broering
authors.forename: X
authors.initials: X
authors.lastname: Rogiers
authors.forename: M
authors.initials: M
authors.lastname: Burdelski
mesh_terms: D000361:Agammaglobulinemia / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology; D001656:Biliary Atresia / Q000601:surgery; D002648:Child; D017074:Common Variable Immunodeficiency / Q000209:etiology; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007223:Infant; D017114:Liver Failure, Acute / Q000601:surgery; D016031:Liver Transplantation / Q000009:adverse effects*; D016131:Lymphocyte Subsets
chemical_list: D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous